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INTRODUCTION 
 
  
Sepsis is one of the commonest cause for hospital admissions 
worldwide. Its a major health concern affecting millions of people around 
the world. In developing countries like India, infections causing more 
mortality and morbidity. Sepsis and related organ dysfunction reduces the 
quality of life of people, thereby reducing the productivity of the country.  
 
The speed and appropriateness of therapy administered in the 
initial hours are likely to influence the outcome. Early recognition of 
sepsis before the development of organ impairment is of utmost 
significance. Pathophysiology of sepsis is needed for better understanding 
of host response to various infections and for diagnosis and treatment.  
 
Infection causes a change in cholesterol composition. High density 
lipoproteins(HDL) possess several biological functions. During 
infections, HDL level decreases very rapidly. HDL influences humoral 
and innate immunity by activation of complement system and 
neutralisation of toxins, hence playing a critical role in sepsis. Studies 
have shown low levels of HDL in sepsis and its level improves with the 
recovery. So HDL level can help in the assessment of prognosis in 
patients with sepsis. 
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 Several severity of illness scoring systems were developed and 
validated over  years. Such scores help in stratifying the patients and help 
in prediction of disease outcome depending on certain clinical and 
laboratory parameters. These scoring systems aid in objective evaluation, 
improving triage, theraputic descision making, medical administration 
and medical auditing. 
 
Sequential organ failure assessment (SOFA) score is one such 
scoring system used for sepsis related organ dysfunction severity and 
prognosis. Acute physiology and chronic health evaluation  (APACHE) II 
score is widely used in critically ill patients for prognostication and 
mortality prediction. 
 
In this study, HDL levels were measured in patients having sepsis . 
SOFA score and APACHE II score were calculated for each patient 
included in the study. HDL levels are correlated for patients having 
sepsis.  Then the calculated SOFA and APACHE II scores were 
correlated in study sample.   
 
 
 
 
AIMS AND OBJECTIVES 
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AIMS AND OBJECTIVES 
 
Primary objective:  
         To study the serum level of HDL in patients with sepsis admitted in 
the medical wards. 
 
Secondary objective: 
 1.To study the correlation of HDL levels with SOFA score. 
 2. To study the correlation of HDL levels with APACHE II score. 
      
 
 
 
 
 
                   
 
 
 
 
REVIEW OF LITERATURE 
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REVIEW OF LITERATURE 
SEPSIS  
 Sepsis occurs as a complication of any serious infection, which 
leads to various morbidity and mortality. The onset of infection causes 
cytokine release that produces various systemic responses like 
generalised vasodilatation , increased  capillary permeability and 
leucocyte infiltration , causing  generalised tissue damage. Severe sepsis 
can lead on to a condition termed “multi organ dysfunction syndrome 
(MODS)” which has a high mortality even in advanced health care 
units.Though there are recent advances in intensive and emergency 
medicine, sepsis control remains to be in great challenge.  
 
Sepsis can present with varied manifestations and the health care 
providers has to be trained enough in early recognition of sepsis, its 
related complications and management  . This is achieved by knowing the 
various  etiologies, pathophysiology, efficent tools in diagnosis with a  
evidence based treatment strategies  and a proper health care system at all 
levels.  
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Definition, epidemiology, pathophysiology, clinical manifestations, 
major complications, laboratory investigations, diagnosis and 
management of sepsis are disscussed in following sections. Metabolism 
of high density lipoprotein(HDL) , its role in sepsis, scoring systems like  
sequential(sepsis-related) organ failure assessment(SOFA) score and 
acute physiology and chronic health evaluation II(APACHE II) score and 
their importance are to be disscussed in the following sections. 
 
HISTORY OF SEPSIS 
 Hippocrates (ca.460- 370 BC) was the first person to use the term 
“Sepsis”  which was  derived from the Greek word “sipsi” that means “ 
make rotten ” .  During  1000 BC , Ibn Sina found that fever and “ 
putrefaction of blood ” were interrelated to each other. 
 
 In seventeenth century Hermann Boerhave derived that sepsis was 
caused  by the toxic substances present in the air.  In the early nineteenth 
century Justus Von Liebig explained the reason that sepsis is due to the 
contact between oxygen and wounds. In the 18th century, Semmelweis 
discovered the co-relation between contaminated hands and puerperal 
infections. He showed that a simple procedure like hand washing by 
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using chlorinated lime solution before a gynaecological examination will 
decrease the incidence of puerperal sepsis. 
 
Louis Pasteur discovered microbes and also said that these 
microbes could cause disease. He also explained  that these microbes in 
fluids can be destroyed by heating and thus the concept of sterilisation 
was born. Joseph Lister did landmark studies in the field of  anti septic 
management with carbolic acid (known as  the antiseptic method). The 
German physicians Lennhartz and Schottmuller proposed that sepsis is  
spreading  into the blood stream from the primary source of infection 
through the bacterial toxins rather than the bacteria per se. 
 
In the pre antibiotic era, death rate was high in sepsis. Those 
patients were observed to have a low blood pressure, which was termed 
as septic shock. After the second world war, antibiotics were introduced, 
since then sepsis mortality was reduced. 
 
 In the late nineteen sixties , Asbough noted that severe sepsis could 
result in  intense inflammatory response , particularly  in the respiratory 
system causing   diffuse alveolar infiltrates, known as  Adult Respiratory 
Distress Syndrome ( ARDS ).  Similar studies showed that sepsis occurs 
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secondary to a dysregulated immune response and not merely by the 
direct toxic effects of the  microbes. 
 
With the advent of various micro organisms and introduction of 
novel antibiotics, sepsis management flourished to greater extent. In the 
year 1991, an international consensus conference was organised by the 
american college of chest physicians (ACCP) and the society of critical 
care medicine (SCCM), where the spectrum of sepsis and allied 
conditions were defined1. 
 The revision of this was done in 2001. The surviving sepsis 
campaign were published in 2004 and revised in 2008. In the year 2012, 
these guidelines were updated2. In 2016, the third international consensus 
definitions for sepsis and septic shock(sepsis-3) was released3. 
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DEFINITIONS 
 
 Based on the consensus among international experts specific 
definitions of sepsis and its related conditions have been defined. 
 
SIRS or systemic inflammatory response syndrome4 may be defined 
as the presence of two or more of the following variables 
 
1) Temp < 36 or >38.3 degree Celsius 
2) Heart rate > 90 
3) Respiratory rate > 20 
4) WBC count > 12, 000 or < 4,000 or band forms more than 10 % 
 
 The term infection refers to the presence of micro organisms in an 
otherwise normally sterile body cavity or fluid (eg Urinary Tract ) or the 
presence of an inflammatory  response to microbes in body cavity or fluid 
that normally harbour micro organisms ( eg GIT ). 
 
Sepsis may be defined as the presence of two or more criteria of 
SIRS in the context of a documented or clinically suspected infection . 
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But the diagnostic criteria of sepsis was further modified in  2001 - 
international conference convened by the Society Of Critical Care 
Medicine ( SCCM ) , European Society of Intensive Care Medicine 
(ESICM) , American College Of Physicians ( ACCP ) , American 
Thoracic Society (ATS) and Surgical Infection Society (SIS)5. It includes 
the following parameters , as shown in the following table 
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Septic shock is defined as the presence of persistent hypotension  despite  
adequate fluid resuscitation6. 
 
 MODS or Multi Organ Dysfunction Syndrome
the clinical syndrome 
potentially reversible dysfuncti
Thus the above told terms belong to
sepsis. 
THE SPECTRUM OF SEPSIS
 
SEPSIS 
11 
7
 may be defined as 
which is associated with progressive and 
on of two or more organ systems.
 the continuous spectrum of 
 AND ASSOCIATED MORTALITY
 
– A DISEASE CONTINUUM 
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According to the Third International consensus Definitions for Sepsis and 
Septic Shock (Sepsis – 3)8, released in 2016 recommends new terms and 
definitions as given in the box below. The concept of SIRS was 
universaly declared by the task force to be unhelpful.This consensus 
recommends SOFA score for defining sepsis. SOFA score is calculated as 
shown in the table below. 
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*At least 2 of the above should present for rapid identification of 
suspected sepsis patients. 
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EPIDEMIOLOGY 
 According to the world sepsis declaration 2016, sepsis is the most 
common and less noticed illness in the world. Around the world, 20 to 30 
million people are found to be affected by sepsis related illness every 
year. Among these 6 million cases are of neonatal and childhood sepsis 
and around 100,000 cases due to maternal sepsis. Globally one person 
dies due to sepsis every few seconds. 
 
 To address the global burden of sepsis, the need for prevention and 
effective management of sepsis, the Global Sepsis Alliance and the 
World Sepsis Day movement joined with national and international 
bodies and other allied groups are working together .The first World 
Sepsis Congress was organised as an online congress on september, 2016. 
World sepsis day is conducted every year on september 16. The mortality 
rate of severe sepsis is nearly 50%. The incidence of sepsis and its related 
complications are increasing because of the following:  
1. Aging population  
2. Multiple comorbid conditions  
3.  increased immunosuppressive states  
4. Expanding  spectrum of micro organisms 
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 In developed countries sepsis is increasing by an annual rate of 8 
to 13% during the last decade, because of increasing age, more use of 
high risk interventions in all age group, with the development of drug 
resistant and virulent organisms9.In developing countries, malnutrition, 
poverty, lack of accsess to vaccines and timely treatment favours death.  
Sepsis , as a cause of mortality ranks much higher than  the other major 
killer diseases as illustrated by the following picture10. 
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INCIDENCE OF SEPSIS COMPARED WITH INCIDENCE OF OTHER 
MAJOR DISEASES 
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PATHOPHYSIOLOGY OF SEPSIS 
 
 Sepsis is due to the complex interplay between the infective 
pathogen and the host immune system. The innate immune system which 
acts as the first tier of defence against the invading organism, is primarily 
responsible for the sequence of inflammatory responses that falls under 
sepsis. The innate immune system consists of monocytes, macrophages, 
natural killer cells , endothelial cells and the dendritic cells.  When the 
pathogenic organism enters the body , it activates this  non specific innate 
immune response through the  Toll like receptors ( TLR ). These 
receptors are so named because they resemble the toll receptors  found in 
Drosophila. 
 
The TLRs bind to proteins known as Pathogen Associated 
Molecular Patterns ( PAMP ). They are highly conserved sequences 
found in various micro organisms. The PAMPs  are generally composed  
of lipo-polysaccharides  or LPS ( in Gram negative organisms ) and 
petidoglycans ( in Gram positive organsisms ). The TLR sends intra 
cellular signals for the activation of transcription factors like the nuclear 
factor kappa b ( NF KB ). Then there is a production of inflammatory 
molecules like the interleukins ( IL-1 , 6 , 8 ) , tumor necrosis factor alpha 
, cyclo oxygenases and prosta glandins.  This is followed by the 
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secondary adaptive immune response mediated by the T lymphocytes and 
B lymphocytes. The binding between the TLR and the PAMPs are shown 
in the following picture 
 
 There are more than 10 TLRs each having an affinity for different 
antigen. Among them the most important is the TLR 4 which binds to the 
lipopolysaccharide component of Gram negative organisms and thus 
playing an important role in pathogenesis due to Gram negative 
septicemia. It is also important to note that even endogenous substances 
like heparin sulphate , hyaluronate , fibronectin , heat shock proteins , 
fibrinogen and certain polymeric sugars may also stimulate the TLR 
pathway. This is the reason for  development of a systemic inflammatory 
response in the absence of an infection ,in situations like pancreatitis. 
Few of the common TLRs and their specific ligands are depicted in the 
subsequent figure.  
 
  
The invading 
immunity, the vascular endothelium and the coagulation pathways to 
produce the septic response.
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pathogen interacts with  innate immunity, adaptive 
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PATHOGENESIS OF SEPSIS 
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ROLE OF VASCULAR ENDOTHELIUM 
 
 The vascular endothelium plays a vital role in the pathogenesis of 
sepsis. The endothelial cells are stimulated either directly by the bacteria 
or by the bacterial products. The response of the endothelium is 
dependent on the age of the patient , gender , co-morbid conditions , host 
genetic factors and on the characteristics of the invading microbes.  
Disruption of the endothelial function results in structural and functional 
alterations which leads to the following effects like 
 
• Uncontrolled release of vaso active substances like nitric oxide and 
prostacyclins 
• Hyper reactivity of the vascular smooth muscles in response to 
vaso constrictors 
• Adhesion and Migration of leucocytes 
• Platelet activation and aggregation 
• Imbalance between pro coagulants and anti coagulants 
• Increased pro apoptotic substances 
• Loss of barrier function 
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 Hence the septic response is secondary to a complex interaction 
between the components of the pathogen (eg – Lipo polysaccharides , 
peptide glycans ) and the host factors ( innate & adaptive immunity , 
endothelial dysfunction ) as illustrated in the image below 
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ORGAN DYSFUNCTION IN SEVERE SEPSIS 
 Sepsis results in a detrimental effect to major organs in the body 
like the central nervous system , cardio vascular system , coagulation 
pathways , gastro intestinal system , renal system , respiratory system and 
the immune system. Dysfunction of two or more organ systems is known 
as Multi Organ Dysfunction Syndrome ( MODS ). The onset of MODS is 
associated with a very high mortality if associated with immune 
suppression , resistant organisms, advanced age and comorbid conditions. 
 
SEPSIS --  MULTI ORGAN FAILURE 
 
 
 
 
 
27 
 
CARDIO VASCULAR SYSTEM 
 
During 1951, Waisbren et al was the first person to describe the 
myocardial dysfunction seen in sepsis. The reduced systemic resistance 
found in sepsis initially masks the reduced myocardial contractility. As 
the disease progresses there will be frank manifestation of the reduced 
stroke volume and ejection fraction. Cardiovascular dysfunction in sepsis 
has significant role in increase of mortality rates.  Global vaso dilatation, 
increased capillary permeability and   myocardial depression leads to a 
state of tissue hypo perfusion which is indicated by the elevated lactate 
levels. 
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RENAL SYSTEM 
 Renal failure is seen in nearly 20 % cases with severe sepsis. 
Sepsis is remained to be the commonest cause for Acute Kidney Injury  
( AKI ) in the intensive care units. The conventional methods used in the 
detection of AKI namely urinary casts and fractional excretion of sodium 
are not adequate to make an early diagnosis of sepsis related AKI. 
Because of this newer bio markers like Neutrophil Gelatinase Associated 
Lipocalin ( NGAL ), cystatin C, urinary interleukin 18 and Kidney injury 
molecule ( KIM 1 ) are now used in detectig AKI. Some of these bio 
markers may even differentiate between septic AKI and non septic AKI. 
 
Sepsis causes AKI through several pathways like direct 
inflammatory injury, ischemia reperfusion injury, dysregulated 
coagulation, endothelial cell dysfunction and accelerated apoptosis. The 
elevated levels of pro inflammatory substances in sepsis such as TNF 
alpha , interleukins and iterferons  exert a direct toxic effect on the 
glomerular cells and the renal tubular epithelium. The higher levels of 
nitric oxide leads to generalised vaso dilatation with secondary 
hypotension and activation of the  renin – angiotensin axis which causes  
intra renal vasoconstriction and thus the fall in glomerular filtration rate. 
Hypotension , intra   vascular hypovolemia , renal vaso constriction and 
the cytokine storm lead on to acute tubular necrosis. Hence there is a 
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multi directional injury to the renal parenchyma which needs an 
immediate renal replacement therapy. 
 
Some of the treatment aspects in sepsis related AKI are given below : 
• Volume repletion and ionotropic support to maintain a mean 
arterial pressure of atleast 65 mm Hg and a central venous pressure 
of 8-12 mm Hg 
• The vasopressors like nor epinephrine and vasopressin that are 
found effective in septic shock. They should be started as early as 
possible in septic shock 
• Optimal blood glucose control using regular insulin 
• Fenoldopam , a dopamine agonist has shown improvement in  renal 
blood flow and can be tried 
• Activated protein C will decrease the thrombin load and hence 
modulate the endothelial dysfunction. But the trials were proved to 
be ineffective 
• N acetyl cysteine and Atrial Natriuretic Peptide have been found to 
have useful in septic AKI 
• Newer therapeutic intrventions like the use of TLR inhibition , 
suppression of the inducible nitric oxide synthase pathways , 
caspase inhibitors , lysophosphatidic acid and use of mesenchymal 
stem cells 
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• Early initiation of extra corporeal purification of blood which is 
having an extra advantage of removal of excess cytokines 
• Hemofiltration , hemadsorption and renal assist devices have been 
tried 
 
CENTRAL NERVOUS SYSTEM 
 Many patients of severe sepsis develop a septic encephalopathy 
having manifestations like  delirium, confusional states and coma. 
 The development of septic encephalopathy is contributed by the 
following 
a) disruption of the blood brain barrier 
b) intra cranial hemorrhage (due to DIC) 
c) micro infarcts 
d) hypoxic encephalopathy 
e) cytokine excess and 
f) development of metastatic abcesses 
 
Septic encephalopathy can results in residual neurological 
sequelae. They have more potential to develop critical illness 
polyneuropathy. This is because of  the sensori motor axonal 
degeneration which  is  characterised by hypotonic limbs and diminished 
reflexes. Depression and anxiety neuroses are more common in these 
people due to the psychological impact of  prolonged ICU stay. 
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GASTRO INTESTINAL SYSTEM 
 Severe sepsis causes decrease in blood pressure which may lead to 
reduced perfusion pressure in the splanchnic circulation which induces 
liver dysfunction.  Bacterial translocation occurs from the gut and 
endotoxemia. Generally such translocated bacteria and their products will 
be destroyed by the reticulo endothelial system of the liver. Because of 
hepatic ischemia in sepsis these toxins enter the systemic circulation 
directly  and exert its inflammatory effects. 
 
COAGULATION PATHWAYS 
 An imbalance between the pro thrombotic and anti thrombotic 
factors occur , as shown in the following picture 
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 Coagulation pathways are affected in gram negative sepsis in 
which endothelial dysfunction  leading  to disseminated intravascular 
coagulation (DIC). It is a consumption coagulopathy with the presence of 
thrombotic and hemorrhagic problems.  This will lead  to  complications  
of micro angiopathic  hemolytic anemia (MAHA) , acute renal failure and 
intra cranial hemorrhages and infarcts. 
 
IMMUNE DYSFUNCTION 
 Sepsis is so severe enough to dysregulate the immunological 
pathways through the cytokine release thereby resulting in  a state of 
relative immuno suppression. 
 
CUTANEOUS MANIFESTATIONS 
 Sepsis, will either directly or by means of disseminated intra 
vascular coagulation leads to skin lesions like petechiae , purpurae , 
vesicles , blisters , necrosis and gangrene. The disruption of dermal blood 
vessels by the micro thrombi will affect dermis. The cutaneous necrotic 
hemorrhagic lesion known as purpura fulminans is notoriously common 
in septicemia due to Neisseria meningitidis and streptococcus 
pneumoniae. 
 
Musher said that “there are mainly three patterns of involvement of 
the skin in Gram negative sepsis”. 
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1) Cellulitis and thrombophlebitis 
2) Ecthyma gangrenosum in cases of impaired inflammatory response  
          due to neutropenia 
3) Symmetrical peripheral gangrene associated with disseminated  
          intra vascular coagulation. 
  
 Palpable petechiae and purpurae are due to leukocytoclastic 
vasculitis, which are associated with organisms like Neisseria, 
pneumococci and staphylococcus aureus. “A diffuse erythematous 
picture” called erythroderma   seen in toxic shock syndrome caused by 
staphylococcus aureus or streptococcus pyogenes. After two weeks 
desquamation of the skin may occur . 
 
RESPIRATORY SYSTEM 
 In many cases of sepsis, initial presentation may be 
hyperventilation with respiratory alkalosis. In which alveolar and 
interstitial fluid accumulation assoociated  with the recruitment of the 
inflammatory cells and cytokines. This results in the  disruption of the 
alveolar membrane. Indeed there is  a proliferation of the Type II 
pneumocytes which replaces the Type I cells with concomitant surfactant 
decrease. Rapid increase of alveolar exudates, fluid accumulation in the 
interstitium and the fibrotic changes  ultimately leading to most dreaded 
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complication  the so called “Acute Respiratory Distress Syndrome 
(ARDS)” . 
 
The following are the salient feautres of ARDS -  
 I. Onset of a lung injury within one week of the known clinical 
insult 
          II. Chest X ray showing Bilateral opacities  
          III. Fluid overload related to cardiac problems to be ruled out 
          IV. Presence of hypoxemia 
  
 The term “acute lung injury” has been replaced by the newer 
Berlin definitions by varying grades of ARDS. The grading system is 
based on the pAO2 / FiO2 ratios. 
Thus ARDS is classified as 
 
1. Mild ARDS    -  pAO2 / FiO2 :  200 to 300 
2. Moderate ARDS       -  pAO2 / FiO2 :  100 to 200 
3. Severe  ARDS            -  pAO2 / FiO2 :  < 100 
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SEPSIS – ARDS PATHWAY 
 
CHEST X RAY – ARDS 
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INVESTIGATIONS TO BE DONE IN SEPSIS 
The investigations are done to assess the following factors 
1. Source of infection 
2. Severity of infection (especially the organ dysfunction) 
3. Causative micro organisms 
4. Prognostication 
 
 First, the basic investigations are done. The complete blood count 
may show leucocytosis or cytopenias. The serial monitoring of cell 
counts gives an idea about the response to treatment. Septic conditions 
have neutrophilic leucocytosis, typically. However certain infections like 
typhoid , brucellosis , Rocky mountain spotted fever , ehrlichiosis etc 
may have peripheral blood leukopenia. 
 
The liver function tests, renal function tests , coagulation profile 
and arterial blood gas analysis are done to assess the presence and extent 
of organ dysfunctions. Most Often, unexplained hyperbilirubinemia, 
hyper lactatemia, metabolic acidosis, respiratory alkalosis or a 
thrombocytopenia are the earliest markers of  septic process. Radiological 
investigations (chest X ray, X ray- paranasal sinuses, ultrasound of 
abdomen , CT and MRI imaging of relevant areas , echocardiography ) 
are very useful in localising the source of infection. If the facilities are 
available cytokine and bio marker assay may be done. 
37 
 
 Blood cultures and cultures of relevant tissue or fluids ( including 
pus, sputum, CSF, urine, stool, bone marrow, skin lesions ) are  to be 
taken before starting the antibiotics. The blood cultures are taken from 
two or three different venipuncture sites. The volume should be atleast 23 
– 30 ml for  blood culture.   Microscopic examination and Gram staining / 
AFB staining of the infected fluids or tissue samples  may also be done. 
Molecular assays such as polymerase chain reaction will be more 
specific. 
 
Acute phase reactants like  C Reactive Protein ( CRP ) , 
procalcitonin11,12 and the erythrocyte sedimentation rate ( ESR ) are 
helpful  in  assessing the severity of sepsis and its response. Critical 
illness associated adrenal insufficiency can be diagnosed with the help of  
baseline serum cortisol and ACTH levels. 
 
 Better descision making by the physician is by the assessment of 
the prognosis in severe sepsis . Serum lactate levels and serum pro 
calcitonin are particularly useful for prognostication. Prognostic scores 
have been formulated based on some of the common blood investigations 
and clinical variables to guide the treating intensivist. 
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DIFFERENTIAL DIAGNOSIS OF SEPSIS 
Several conditions  can produce a state of hypotension , raised 
body temperature and features of multi organ dysfunction and hence 
mimic sepsis. Some of them are listed below :- 
1. Trauma 
2. Burns 
3. Adrenal insufficiency 
4. Pancreatitis 
5. Drug overdose or drug reaction 
6. Ruptured or dissecting aneurysm of aorta 
7. Thyroid storm 
8. Pulmonary embolism 
9. Occult internal bleed 
10. Cardiac tamponade 
11. Serotonin syndrome 
12. Heat stroke 
13. Anaphylaxis 
14. Post cardio pulmonary bypass 
15. Malignant hyperthermia 
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MANAGEMENT OF SEPSIS 
INITIAL RESUSCITATION 
 Adequate IV fluids have to be infused to maintain targets of 
1. Central venous pressure 8-12 mm Hg 
2. Mean arterial pressure > 65 mm Hg 
3. Venous oxygen saturation > 70 % 
4. Urine output  > 0.5 ml / kg / hr 
5. Normalisation of lactate levels 
 
 The ideal fluids for the initial resuscitation are crystalloids. With 
caution, an initial fluid challenge of about 15 – 30 ml / kg to be given. 
Further fluids are infused based on the hydration status , vitals and urine 
output. Vasopressors and inotropes are considered when the blood 
pressure fails to pick up despite adequate fluid resuscitation. Blood 
products are given if hemoglobin concentration less than 7 gm %. A 
platelet count of < 10,000 per cu mm necessitates platelet transfusion. If 
surgery is planned a higher platelet count of around 50,000 / cu mm is 
maintained to avoid complications. 
 
The algorithm for the initial resuscitation in a case of severe sepsis 
is shown  in the following picture. 
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NUTRITIONAL SUPPORT 
 Adequate calories must be given according to the body weight of 
the patient. Preferred choice is the enteral route. 
 
ANTI BIOTICS  
 Combination of empirical agents are used especially in immuno 
compromised and neutropenic patients. After obtaining culture and 
sensitivity reports  empirical therapy is withdrawn. Classically these 
antibiotics are given for a  period of  7 – 14 days. 
  
 AN ALGORITHM FOR 
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ANTIBIOTIC PROTOCOL IN SEPSIS
 
 
 
 SOURCE CONTROL
 The source of infection should be detected  at first and  necessary 
steps to be taken to eliminate it. S
and fluids are to be considered
standing indwelling vascular and ot
appropriately.   
The doses and effects of drugs used in the management of severe 
sepsis are mentioned in the following table.
 
Key : CO-cardiac output , MAP 
return 
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urgical removal of the infected tissues 
 if it is a closed space infectio
her catheters are to be removed 
 
– mean arterial pressure , SVR 
n. Long 
 
– systemic venous 
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ROLE OF STEROIDS 
 Parenteral hydro cortisone can be given for severe sepsis with 
shock that is unresponsive to intra venous fluids and vasopressors. 
 
MANAGEMENT OF ARDS 
 Ideally ARDS to be managed with mechanical ventilation with 
following parametrs in mind 
 
1. A low tidal volume of around 6 ml / kg is preferred 
2. Plateau airway pressures should be < 30 cm H2O 
3. Higher PEEP is to be used to prevent alveolar collapse 
4. Recruitment manoeuvres and prone positioning have been reported 
to have improved outcomes in studies 
 
GLYCEMIC STATUS 
 An optimal glycemic status , targetting a sugar level of < 180 mg / 
dl is essential for a better  control of sepsis 
 
DIALYSIS 
 Most patients with severe sepsis are prone to develop acute kidney 
injury. Renal replacement therapy may be essential in those patients 
going for renal failure. 
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DVT PROPHYLAXIS 
 As the patients with severe sepsis, who are on prolonged bed 
ridden state, should be given daily small dose of low molecular weight 
heparin to prevent the formation  of deep venous thrombosis ( DVT ).  
For patients with a creatinine clearance of < 30 ml/min it should be used 
cautiously. Patients having hypersensitivity to heparin, alternative choices 
like compression stockings , intermittent pneumatic compression devices 
etc can be tried. 
 
STRESS ULCER PREVENTION 
 Patients suffering from severe sepsis and MODS should be given 
prophylaxis to prevent from  stress ulcers especially in those having a 
tendency to bleed. The proton pump inhibitors like pantoprazole are the 
drug of choice, than histamine receptor blockers. 
 
MONITORING THE ORGAN FUNCTION 
  The organ function parameters are to be monitored throughout the 
course of treatment. It gives an idea regarding the severity of sepsis and 
also about the dose tapering and changing of medications. The following 
chart depicts the variables  to be monitored during management 
 
 
 RISK PROGNOSTICATION IN SEPSIS
 Number of scoring systems have been 
severity , prognosis and 
patients including those 
provide information 
various organs and the possibility
They generally  have two parts 
depending  upon the score. The 
illness if any, functional alt
admission diagnosis. These
and hospital  administrators  to improve their decision making skills. 
They are useful in  
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formulated
assessment of in-hospital mortality in critically ill 
affected  from severe sepsis.
related to the degree of functional 
 of serious morbidity and mortality. 
– a score and a mortality assessment 
parameters considered are age, comorbid 
erations of organs , use of interve
 prognostic scores are helping
better utilisation of hospital resources.
 
 to predict the 
 These systems 
alterationa in  
ntions and 
 the physicians 
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Few of those scores are 
1. APACHE II   { Acute Physiology and Chronic Health Evaluation }  
Score 
2. SAPS  { Simplified Acute Physiology } Score 
3. SOFA  {Sequential or sepsis related Organ Failure Assessment }  
Score 
4. MPM { Mortality Prediction Model} 
 
 Based on the evalution of  these scoring systems, they are 
categorised into generations as shown below 
 
 
  
 In general those data that are objective, highly reproducible and 
easy to measure are used in the scoring systems. Depending on these data 
and associated equations the risk scores are calculated and the patients 
may be classified into varying levels of risk groups. 
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REQUISITES FOR A GOOD PROGNOSTIC SCORING SYSTEM 
 A scoring system can be considered  as best, if it satisfy the 
following  points like 
• Simple 
• Easy to use 
• Universally applicable 
• Reliable and consistent 
• Good sensitivity and specificity 
 
 Among the various scoring systems that are used in the critically ill 
patients , the two systems that have been verified  in many studies and 
shown to be effective prognosticatory tools, are the APACHE II and 
SOFA scores. 
 
APACHE II SCORE 
 The APACHE II or the Acute Physiology And Chronic Health 
Evaluation Score was first formulated by the US researchers led by 
Knaus et al. This model has been upgraded three times following British 
and Irish studies and thus APACHE I , II and III were born. Among these 
the APACHE II has the benefit scores  for age , past comorbid conditions 
and acute physiological parameters. The following 12 parameters are to 
be taken within the first 24 hours of  presentation  
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i. Temperature 
ii. Mean arterial pressure 
iii. Heart rate 
iv. Respiratory rate 
v. pAO2 
vi. arterial pH or serum bicarbonate 
vii. serum potassium 
viii. serum sodium 
ix. serum creatinine 
x. hematocrit 
xi. white blood cell count 
xii. Glasgow coma scale 
  
The following cases in general are not  scored using the APACHE II 
system 
 
• Age of admission  < 16 years 
• Duration of stay in the ward < 8 hours 
• Admission is for primary burns 
• Admission following coronary bypass grafting 
• If the twelve variables within first 24 hours are not available 
The method of calculation of the APACHE II score is shown in the 
subsequent table. 
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APACHE II SCORE CALCULATION CHART 
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SOFA SCORE 
The SOFA or Seqential Organ Failure Assessment score is used to 
monitor the health status of a critically ill patient. This score is the 
summation of six different scores , each of which represents an organ 
system. The organs taken into account for the calculation of SOFA score 
and the corresponding table has been  already dicussed under definitions. 
  
HIGH DENSITY LIPOPROTEINS (HDL): 
Lipoproteins are complex  molecules  composed of number of 
proteins which transport all fat particles  in the body within the water in 
the extracellular space13.There are five types of plasma lipoprotein 
particles namely High density lipoproteins (HDL), Low density 
lipoproteins(LDL), Intermediate density lipoproteins (IDL), Very low 
density lipoproteins(VLDL) and Ultra low density lipoproteins(ULDL) 
commonly called as Chylomicrons and shown below. 
   
HDL contains 80 to 100 proteins per particle and it transports 
hundreds of fat molecules in each particle. The larger  lipoprotein 
particles carry fat molecules to cells, but HDL scavanges the fat from 
cells. Higher level of HDL is strongly associated with 
the formation of atherosclerosis
atherosclerotic plaque rupture, sudden myocardial infarction, cerebro 
vascular accidents and other vascular diseases
cholesterol”. 
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14
. This will reduce the chance of 
15
,
16
.Hence 
 
 
 the decrease in  
the name “good 
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STRUCTURE OF HDL 
 
 
METABOLISM OF HDL 
The densest lipoprotein , having high proportion of proteins to 
lipids. The apolipoproteins like apoA-I and apoA-II are abudantly seen. A 
rare variant, ApoA-I Milano is more effective in preventing 
atherosclerosis. The liver synthesizes these lipoproteins as complexes of 
apolipoproteins and phospholipids. They mimic the cholesterol free 
flattened spherical lipoprotein particles. These compounds are able to 
pick up cholesterol, which are carried internally in the cells by binding 
with the ATP- binding cassette transporter  A1(ABCA1)17. An enzyme in 
the plasma called lecithin – cholesterol acyl transferase(LCAT) helps in 
conversion of free cholesterol to cholesterol esters. This complex then 
bind with the core lipoprotein  molecule and helps in forming the fresh 
spherical shape HDL. 
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 Then the HDL gains bigger size as they go through the blood 
stream  and acquire more cholesterol and phospholipid particles from 
cells and rest of the lipoproteins.  This action is carried out by the 
interaction to ABCG1 transporter and the phospholipid transport protein 
(PLTP). 
 
By the direct and indirect pathways HDL is tranporting cholesterol 
to liver and the organs like adrenal glands, ovary and testis for the 
synthesis of steroids. Receptors of HDL  like scavenger receptor BI (SR-
BI) helps in the selective uptake of cholesterol from HDL. Indirect 
pathway is most common in human beings carried out by cholesterol 
ester transfer protein (CETP). 
 
Cholesteryl esters of HDL are exchanged by triglycerides of 
VLDL, which is carried out by the protein CETP. Because of this reaction 
VLDLs are transformed to LDL  and eventually they are cleared by the 
LDL receptor pathway. The triglycerides in HDL are unstable, which are 
degraded by the hepatic lipase  and the remaining small HDL molecules 
will again begin the uptake of cholesterol from cells. HDL metabolism is 
depicted in the picture shown below. 
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The cholesterol reaching the liver is excreted through the bile and 
thus reaching the intestines by  directly or indirectly  after transforming 
into bile acids. The uptake  of  cholesterol from “lipid laden 
macrophages, termed as foam cells” in the atherosclerotic vessels  to the 
liver and secreted via bile. This is known as “reverse cholesterol 
transport”, which is the ultimate protective function of  HDL against 
atherosclerosis. 
The protein and lipid constituents of HDL are helpful in inhibiting  
various reactions involved in atherogenesis  like oxidation, inflammation, 
endothelial activation, coagulation and aggregation of platelets. They also 
 play a role in infections and in chronic inflammatory states.The role of 
HDL is illustrated in the followi
 
 
ROLE OF HDL IN INFECTIONS AND SEPSIS
 HDL has many important functions in addition to its role in 
atherosclerosis. Those are proinflammatory, 
antithrombotic roles , which are depicted in the picture below
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ng picture. 
 
antiinfllammatory and 
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Infections cause reasonable alterations in lipid metabolism and in 
the composition of lipoproteins18. In these situations, there is an increase 
in the levels of triglycerides and VLDL cholesterol and decrease in levels 
of HDL and LDL cholesterol19. Endotoxin release from infections alters 
the composition of HDL and size by the reduction of phospholipids and 
apolipoprotein (apo) A-I, serum amyloid A (SAA) and secretory 
phospholipase A2 (sPLA2) are grossly increased. Eventhough there is no 
change in the total particle number, a marked decrease in the number of 
small and medium size particles is noted. This is shown in the following 
picture 
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Low serum levels of HDL is inversely proportional to the severity 
of sepsis and is related to an extensive systemic inflammatory response. 
This cholesterol binds with the lipopolysaccharides (LPS) of gram 
negative organisms and lipoteichoic acid (LTA)  of gram positive 
organisms and neutralises them20. Thus help in clearing of those toxins. 
During parasitic infections, particular component of HDL namely apoL-1, 
which gives innate immunity against Trypanosomes by causing swelling 
of lysosomes and thereby killing them21. 
 
In case of viral infections, there are protein molecules like ABCA1 
and SR-BI causing modulation of cholesterol bioavailability in the lipid 
rafts , which favours the entry of  the virus into the cells. The following 
picture shows the role of  HDL in infections 
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Studies have shown benefits of recombinant HDL and apoA-I 
adminstrations during infections. Hence serum HDL level measured 
during infections will help to assess the severity of illness. In the mean 
time other causes of low HDL to be ruled out. Patients with sepsis, 
having low HDL level indicates disease severity.Such patients are given 
intensive medical attention with the anticipation of MODS.  Serial 
monitoring will assist in prognosis and disease outcome.  
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 In this study sepsis patients are selected according to the inclusion 
and exclusion criteria. On the day of admission, SOFA  and APACHE II  
scores were calculated to assess the severity and serum HDL levels were 
estimated. 
 
 
  
 
  
 
 
 
 
 
 
 
 
 
 
 
MATERIALS AND METHODS 
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MATERIALS AND METHODS 
 
Study Centre  
Institute of Internal Medicine, Madras Medical  College and Rajiv 
Gandhi Govt General Hospital, Chennai 
 
Duration of Study   
6 months 
 
Study Design 
Descriptional study 
 
Sample Size 
100 patients 
 
Inclusion Criteria 
 Patients of age greater than 18 years with sepsis 
 
Exclusion Criteria 
1. Patients on statins 
2. Chronic liver disease 
3. Chronic kidney disease 
4. Thyroid dysfunction 
5. Diabetes mellitus 
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6. Malignancy 
7. Chronic inflammatory conditions like Human immuno deficiency virus  
    infection(HIV), Systemic lupus erythematosis(SLE), Rheumatoid  
     arthritis(RA) 
8. Patients with malabsorption 
9. Pregnancy 
 
Data Collection and Methods 
Patients are subjected to  history taking ,  clinical examination and 
biochemical investigations were done. 
 
Materials and Methods 
Patients admitted in medical wards of RGGGH were selected 
according to the inclusion and exclusion criteria. They were subjected to 
detailed history taking and physical examination after obtaining proper 
written consent. Blood samples were collected and sent for biochemical 
analysis. SOFA and APACHE II scores were calculated on the day of 
admission. HDL levels were estimated and correlated with SOFA and 
APACHE II scores. 
 
Procedure / Investigation Details 
Serum HDL estimation by enymatic method using fully automated 
analyser 
62 
 
Analysis Plan 
 SPSS, Epi INFO softwares 
 
Sponsorship  
 No  
 
Conflict of interest 
 None 
OBSERVATIONS AND RESULTS  
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OBSERVATION AND RESULTS 
TABLE AND BAR DIAGRAM SHOWING AGE DISTRIBUTION 
IN THE STUDY SAMPLE 
AGE_GROUP 
 Frequency Percent   
Valid 
20-30 22 22.0   
31-40 21 21.0   
41-50 28 28.0   
51-60 29 29.0   
Total 100 100.0   
 
 
 
 
 
 
 
22%
21%
28%
29%
0%
5%
10%
15%
20%
25%
30%
35%
20-30 31-40 41-50 51-60
Age Group
  
TABLE AND BAR DIAGRAM SHOWING GENDER 
DISTRIBUTION IN THE STUDY SAMPLE
 
Valid 
MALE 
FEMALE 
Total 
 
 
 
 
 
34%
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SEX 
Frequency Percent  
66 66.0  
34 34.0  
100 100.0  
 
66%
GENDER
 
 
 
 
 
 
Male
Female
 TABLE AND PIE CHART SHOWING DISTRIBUTION OF 
TEMPERATURE 
 
Valid 
NORMAL
Hyperthermi
a
Hypothermi
a
Total
 
 
  
In this study, hyperthermia was observed to be of 54% of study 
sample. 
26%
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IN THE STUDY SAMPLE
 
TEMPERATURE 
Frequency Percent 
 20 20.0 
 
54 54.0 
 
26 26.0 
 100 100.0 
20%
54%
TEMPERATURE
 
 
NORMAL
Hyperthermia
Hypothermia
 TABLE AND  PIE CHART  
SYSTOLIC  BP  IN  STUDY SAMPLE
Valid 
more than 100
Less than 100
 
 
 
In this study systolic BP less than 100 mmHg was observed in 53% 
of samples. 
 
 
 
53
66 
SHOWING DISTRIBUTION OF 
SYSTOLIC_BP 
 Frequency Percent 
 47 47.0 
 53 53.0 
Total 100 100.0 
47
SYSTOLIC_BP
 
 
more than 100
Less than 100
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TABLE AND PIE CHART SHOWING DISTRIBUTION  OF 
RESPIRATORY  RATE IN THE STUDY SAMPLE 
 
RESPIRATORY_RATE 
 Frequency Percent 
Valid 
<22 69 69.0 
>22 31 31.0 
Total 100 100.0 
 
 
 
 
 In this study respiratory rate less than 22 was observed in 69% of 
samples. 
 
 
69
31
RESPIRATORY_RATE
<22
>22
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TABLE AND PIE CHART SHOWING DISTRIBUTION OF 
VENTILATORY SUPPORT IN THE STUDY SAMPLE 
 
VENTILATORY_SUPPORT 
 Frequency Percent 
Valid 
YES 42 42.0 
NO 58 58.0 
Total 100 100.0 
         
         
  
 
 
 In this study patients without ventilatory support were found to be 
58%. 
 
42%
58%
VENTILATORY_SUPPORT
YES
NO
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TABLE AND PIE CHART SHOWING DISTRIBUTION OF HDL 
IN THE STUDY SAMPLE 
 
HDL_GROUP 
 Frequency Percent 
Valid 
NORMAL (35-80) 20 20.0 
ABNORMAL  <35 80 80.0 
Total 100 100.0 
 
 
 
 
 In this study 80% of samples were found to have low HDL levels. 
 
 
 
20%
80%
HDL_GROUP
NORMAL (35-80)
ABNORMAL  <35
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TABLE SHOWING  DISTRIBUTION OF GCS, TOTAL COUNT, 
PLATELET COUNT, BILIRUBIN, CREATININE, APACHE II & 
SOFA SCORE IN THE  STUDY SAMPLE 
  
HDL_GROUP N Mean Std. 
Deviation 
Std. Error 
Mean 
T 
VALU
E 
P 
VALUE 
GCS 
NORMAL (35-80) 20 14.90 0.31 0.07 
6.524* P<0.0001 ABNORMAL  <35 80 10.59 2.94 0.33 
TOTAL_
COUNT 
NORMAL (35-80) 20 7160.00 4701.11 1051.20 
2.26* 0.026 ABNORMAL  <35 80 11628.75 8501.50 950.50 
PLATEL
ET_COU
NT 
NORMAL (35-80) 20 35690.00 20971.43 4689.35 
4.123* P<0.0001 ABNORMAL  <35 80 21175.00 11840.58 1323.82 
BILIRUB
IN 
NORMAL (35-80) 20 0.95 0.27 0.06 
11.202
* P<0.0001 ABNORMAL  <35 80 4.14 2.49 0.28 
CREATI
NINE 
NORMAL (35-80) 20 0.98 0.24 0.05 
12.191
* P<0.0001 ABNORMAL  <35 80 3.48 1.77 0.20 
APACHE
_II_SCO
RE 
NORMAL (35-80) 20 4.15 0.67 0.15 
15.985
* P<0.0001 ABNORMAL  <35 80 24.13 11.10 1.24 
SOFA_S
CORE 
NORMAL (35-80) 20 3.50 0.76 0.17 
8.368* P<0.0001 ABNORMAL  <35 80 13.31 5.21 0.58 
 
 GCS, total count, platelet count, serum bilirubin, serum creatinine, 
APACHE II and SOFA scores  were found to have significant correlation 
with HDL levels. 
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 SHOWING DISTRIBUTION OF GCS AND 
 ABNORMAL 
STUDY POPULATION 
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 BAR DIAGRAM SHOWING DISTRIBUTION OF 
COUNT & BILIRUBIN AMONG HDL NORMAL / 
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 BAR DIAGRAM SHOWING DISTRIBUTION OF 
APACHE II SCORE AMONG HDL NORMAL / 
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CREATININE & 
ABNORMAL GROUPS 
-80) ABNORMAL  <35
0.98
3.48
MEAN CREATININE
-80) ABNORMAL  <35
4.15
24.13
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 BAR DIAGRAM COMPARING SOFA 
CORRELATIONS
HDL 
Pearson Correlation
Sig. (2
**. Correlation is significant at the 0.01 level (2
 
 
SOFA and APACHE II scores were having significant correlation with 
HDL level. 
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SCORE AMONG NORMAL 
/ ABNORMAL HDL GROUP 
 
 SOFA_SCORE APACHE_II_SCORE
 -.916** -.914
-tailed) .000 .000
N 100 
-tailed). 
-80) ABNORMAL  <35
3.5
13.31
MEAN SOFA SCORE
 
 
GCS 
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SCATTER DIAGRAM SHOWING CORRELATION BETWEEN 
APACHE II SCORE AND HDL LEVEL 
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SCATTER DIAGRAM SHOWING CORRELATION BETWEEN 
SOFA SCORE AND HDL LEVEL 
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TABLES SHOWING  AGE & GENDER DISTRIBUTION AMONG 
HDL GROUPS 
Crosstab 
 
AGE_GROUP 
Total 
20-30 31-40 41-50 51-60 
HDL_GROUP 
NORMAL 
(35-80) 
Count 6 5 2 7 20 
% within 
HDL_GROUP 30.0% 25.0% 10.0% 35.0% 100.0% 
ABNORMAL  
<35 
Count 16 16 26 22 80 
% within 
HDL_GROUP 20.0% 20.0% 32.5% 27.5% 100.0% 
Total 
Count 22 21 28 29 100 
% within 
HDL_GROUP 22.0% 21.0% 28.0% 29.0% 100.0% 
Pearson Chi-Square=4.121 P=0.249 
 
Crosstab 
 
SEX 
Total 
MALE FEMALE 
HDL_GROU
P 
NORMAL (35-
80) 
Count 10 10 20 
% within 
HDL_GROUP 50.0% 50.0% 100.0% 
ABNORMAL  
<35 
Count 56 24 80 
% within 
HDL_GROUP 70.0% 30.0% 100.0% 
Total 
Count 66 34 100 
% within 
HDL_GROUP 66.0% 34.0% 100.0% 
Pearson Chi-Square=2.852  P=0.091 
 
 
 
 
 TABLE  AND BAR DIAGRAM 
DISTRIBUTION  AMONG  HDL GROUPS
 
HDL_GROUP 
NORMAL (35
ABNORMAL  <35
Total 
 
 
 
 
 
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
NORMAL (35
78 
 SHOWING  TEMPERATURE  
 
Crosstab 
TEMPERATURE 
NORMAL Hyperthermia Hypothermia
-80) 
Count 10 10 
% within 
HDL_GRO
UP 
50.0% 50.0% 
 
Count 10 44 
% within 
HDL_GRO
UP 
12.5% 55.0% 32.5%
Count 20 54 
% within 
HDL_GRO
UP 
20.0% 54.0% 26.0%
-80) ABNORMAL  <35
50%
13%
50%
55%
0%
33%
Total 
 
0 20 
0.0% 100.0% 
26 80 
 100.0% 
26 100 
 100.0% 
 
Hypothermia
Hyperthermia
NORMAL
 TABLE  AND  BAR  DIAGRAM  SHOWING  DISTRIBUTION OF 
SYSTOLIC  BP AMONG HDL GROUPS
HDL_GROUP 
NORMAL (35
ABNORMAL  <35
Total 
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NORMAL (35
79 
Crosstab 
 
SYSTOLIC_BP
more than 100 Less than 100
-80) 
Count 19 
% within HDL_GROUP 95.0% 
 
Count 28 
% within HDL_GROUP 35.0% 
Count 47 
% within HDL_GROUP 47.0% 
-80) ABNORMAL  <35
95%
35%
5%
65%
 
 
Total 
 
1 20 
5.0% 100.0% 
52 80 
65.0% 100.0% 
53 100 
53.0% 100.0% 
 
less than 100
more than 100
 TABLE  AND  BAR  DIAGRAM  SHOWING  DISTRIBUTION  OF  
RESPIRATORY  RATE  AMONG  HDL  GROUPS
HDL_GROUP 
NORMAL (35
ABNORMAL  <35
Total 
Pearson Chi-Square=11.232* P<0.001
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NORMAL (35
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80 
 
Crosstab 
 
RESPIRATORY_RATE
<22 
-80) 
Count 20 
% within HDL_GROUP 100.0% 
 
Count 49 
% within HDL_GROUP 61.3% 
Count 69 
% within HDL_GROUP 69.0% 
 
-80) ABNORMAL  <35
61%
39%
 
 
Total 
>22 
0 20 
0.0% 100.0% 
31 80 
38.8% 100.0% 
31 100 
31.0% 100.0% 
 
Respiratory rate>22
Respiratory rate <22 
 BAR  DIAGRAM  SHOWING  APACHE II  & SOFA  SCORE 
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TABLE  SHOWING CORRELATION OF  SOFA & APACHE II 
SCORE AMONG  LOW HDL GROUPS 
 
Group Statistics FOR 80 ABNORMAL CASES   
 HDL_15 N Mean Std. Deviation 
Std. 
Error 
Mean 
T value P value 
APACHE_II
_SCORE 
Less than 15 43 33.7674 2.63527 .40187   
More than 15 37 12.9189 4.68673 .77049 24.96* P<0.001 
SOFA_SCO
RE 
Less than 15 43 17.7442 1.81388 .27661 21.123
* 
P<0.001 
More than 15 37 8.1622 2.24244 .36865   
 
 
 APACHE II and SOFA scores having significant correlation with 
low HDL groups. 
 
 
 
 
  
DISCUSSION 
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DISCUSSION 
 
 This study is an descriptional study done in patients admitted with 
sepsis. According to the inclusion and exclusion criteria, patients in 
medical wards of RGGGH were selected. After obtaining proper written 
consent, they were subjected to detailed history taking and physical 
examination. Biochemical analysis of collected blood samples were done.  
SOFA and APACHE II scores were calculated on the day of admission. 
HDL levels were estimated and correlated with SOFA and APACHE II 
scores.  
 
In developing countries like India, sepsis remains to be the major 
cause of mortality and morbidity. Early recognition and prompt treatment 
will prevent the adverse outcome. SOFA and APACHE II scores help in 
prognostication of the disease. Serum HDL is one of the widely used 
investigation in general and is available in most of the centres. The 
concept of decrease in HDL level in sepsis was used in this study and it 
has been evaluated. Some of the studies are mentioned below. 
 
A study of serum HDL levels in severe sepsis patients done by 
Naresh Monigari et al showed significant association of low HDL value 
on day 1 with mortality22. 
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In a study done by Sunil B Kumarasamy et al showed plasma 
concentrations of HDL were low in severe sepsis patients and reflecting 
the severity of the disease23. 
 
A  study published by Chien et al showed that low HDL level on 
day 1of severe sepsis is significantly associated with an increase in 
mortality and  adverse clinical outcome24. 
 
In this study, serum level of HDL was decreased in 80% of 
patients. There was a significant correlation between sepsis and HDL 
level. In our sample, proportion of males got admitted was higher  than 
females. Hyperthermia, systolic BP < 100 mm Hg, respiratory rate < 22/ 
minute and patients without ventilatory support were in higher 
proportion.  
 
SOFA and APACHE II scores were inversely proportional with 
HDL levels. In patients having low HDL levels, these scores were very 
high and showing poor prognosis. Significant correlation was found 
between sepsis and HDL and also between HDL and these two scores. 
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LIMITATIONS OF THE STUDY 
 
 A multicentric study with  a larger sample size and longer follow 
up is needed to assess the predictive power of HDL values and the 
scoring systems such as SOFA and APACHE II. 
 
 
 
 
 
 
 
 
 
 
 
  
CONCLUSION 
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CONCLUSION 
 
 
Significant correlation was present between the patients with sepsis 
and serum HDL  level. Low HDL values were observed  in patients with 
severe sepsis and in those having severe organ dysfunction.  
 
Higher values of SOFA and APACHE II scores were associated 
with low HDL levels. HDL level has significant correlation with SOFA 
and APACHE II scores. In this study HDL level less than 15 mg/dl have 
higher SOFA and APACHE II scores, indicating poor prognosis in such 
patients. Hence a simple investigation like HDL can be used as a 
prognostic marker in sepsis. 
 
Serial monitoring of patients with SOFA score, APACHE II score 
and HDL values are essential for better than a single value, for better 
prognostication and best clinical outcome in patients with sepsis. 
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